Medivation prostate cancer drug well-tolerated in trial

(Reuters) - Medivation Inc's experimental prostate cancer pill caused fewer serious side effects in clinical trial patients than a placebo treatment, according to full results from a pivotal study announced on Tuesday. The news sent shares of Medivation up more than 11 percent to $61.75 in after-hours trading. Medivation and partner Astellas Pharma Inc reported in November that the trial had ...

Exercise a Good Pick-Me-Up After Cancer Treatment: Study

WEDNESDAY, Feb. 1 (HealthDay News) -- Exercise can improve the health, energy and well-being of cancer patients after they've completed their main cancer treatment, a new review finds.

Gene Test to 'Sort' Lung Cancer Cases?

In a study published in the journal Lancet Thursday, researchers describe a new genetic test to determine which of the surgically removed lung cancers will return.

Lung Cancer Cases Could Be Genetically Sorted With New Test

More than 200,000 Americans were diagnosed with lung cancer in 2011, and when a diagnosis is made, often the question becomes whether to treat the cancer with potentially dangerous chemotherapy or opt for surgery to remove the affected tissue. In about 50% of patients, the cancer will return, in which case chemotherapy might have been [...] Lung Cancer Cases Could Be Genetically Sorted With New ...

Genetic Tests On Lung Cancer May Someday Guide Treatment

Lung cancers are not all the same. Part of the difference is in the cancer's genetics.